Loading
Latest filing published 15 Jul 2026 for IX BIOPHARMA LTD., €473k.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by Eddy Lee Yip Hang on record concern IX Biopharma Ltd. Over a trading history stretching from 2 July 2021 to 15 July 2026, the count stands at 12 filings.
The open-market side counts 4 purchases for €2.3M alongside 1 sale for €1.7M. The totals exclude 1 filing filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2026, the count stands at 2 purchases and 1 sale.
A typical purchase (the median) is worth €473k.
The newest entry dates from 15 July 2026: an open-market purchase of €473k, in IX Biopharma Ltd. Typically, a trade is published a median of 3 days after it takes place. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by SGX. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations